标题
GLP-1-Based Strategies: A Physiological Analysis of Differential Mode of Action
作者
关键词
-
出版物
PHYSIOLOGY
Volume 29, Issue 2, Pages 108-121
出版商
American Physiological Society
发表日期
2014-03-02
DOI
10.1152/physiol.00009.2013
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- GLP-1 Receptor Stimulation Reduces Amyloid-β Peptide Accumulation and Cytotoxicity in Cellular and Animal Models of Alzheimer's Disease
- (2017) Yazhou Li et al. JOURNAL OF ALZHEIMERS DISEASE
- Clinical Implications of Cardiovascular Preventing Pleiotropic Effects of Dipeptidyl Peptidase-4 Inhibitors
- (2012) Steven G. Chrysant et al. AMERICAN JOURNAL OF CARDIOLOGY
- GLP-2 receptor in POMC neurons suppresses feeding behavior and gastric motility
- (2012) Xinfu Guan et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders
- (2012) Isidro Salcedo et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus: a pre-specified, prospective, and adjudicated meta-analysis of a phase 3 programme
- (2012) Odd Johansen et al. Cardiovascular Diabetology
- Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2012) S. E. Inzucchi et al. DIABETES CARE
- Liraglutide: short-lived effect on gastric emptying-long lasting effects on body weight
- (2012) J. Jelsing et al. DIABETES OBESITY & METABOLISM
- A randomized non-inferiority study comparing the addition of exenatide twice daily to sitagliptin or switching from sitagliptin to exenatide twice daily in patients with Type 2 diabetes experiencing inadequate glycaemic control on metformin and sitaglipti
- (2012) R. Violante et al. DIABETIC MEDICINE
- Glucagon-like peptide-1 of brainstem origin activates dorsomedial hypothalamic neurons in satiated rats
- (2012) E. Renner et al. PEPTIDES
- Efficacy and Safety of Long-Acting Glucagon-Like Peptide-1 Receptor Agonists Compared with Exenatide Twice Daily and Sitagliptin in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
- (2011) Nicole R Pinelli et al. ANNALS OF PHARMACOTHERAPY
- Molecular mechanisms underlying bile acid-stimulated glucagon-like peptide-1 secretion
- (2011) HE Parker et al. BRITISH JOURNAL OF PHARMACOLOGY
- Neuroprotective properties of GLP-1: theoretical and practical applications
- (2011) Jens Juul Holst et al. CURRENT MEDICAL RESEARCH AND OPINION
- Beneficial Effects of Exendin-4 on Experimental Polyneuropathy in Diabetic Mice
- (2011) T. Himeno et al. DIABETES
- Rapid Tachyphylaxis of the Glucagon-Like Peptide 1-Induced Deceleration of Gastric Emptying in Humans
- (2011) M. A. Nauck et al. DIABETES
- The gut-brain axis: a major glucoregulatory player
- (2011) R. Burcelin DIABETES & METABOLISM
- Beyond glucose lowering: Glucagon-like peptide-1 receptor agonists, body weight and the cardiovascular system
- (2011) B. Vergès et al. DIABETES & METABOLISM
- Effect of sitagliptin therapy on postprandial lipoprotein levels in patients with type 2 diabetes
- (2011) A. J. Tremblay et al. DIABETES OBESITY & METABOLISM
- DURATION-2: efficacy and safety of switching from maximum daily sitagliptin or pioglitazone to once-weekly exenatide
- (2011) C. Wysham et al. DIABETIC MEDICINE
- Dipeptidyl peptidase-4 inhibition increases portal concentrations of intact glucagon-like peptide-1 (GLP-1) to a greater extent than peripheral concentrations in anaesthetised pigs
- (2011) K. R. Hjøllund et al. DIABETOLOGIA
- Peripheral and Central GLP-1 Receptor Populations Mediate the Anorectic Effects of Peripherally Administered GLP-1 Receptor Agonists, Liraglutide and Exendin-4
- (2011) Scott E. Kanoski et al. ENDOCRINOLOGY
- Physiological and Pharmacological Mechanisms through which the DPP-4 Inhibitor Sitagliptin Regulates Glycemia in Mice
- (2011) Aurélie Waget et al. ENDOCRINOLOGY
- GLP-1 Neurons in the Nucleus of the Solitary Tract Project Directly to the Ventral Tegmental Area and Nucleus Accumbens to Control for Food Intake
- (2011) Amber L. Alhadeff et al. ENDOCRINOLOGY
- Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice
- (2011) Benjamin J. Lamont et al. JOURNAL OF CLINICAL INVESTIGATION
- Processing of proglucagon to GLP-1 in pancreatic α-cells: is this a paracrine mechanism enabling GLP-1 to act on β-cells?
- (2011) N M Whalley et al. JOURNAL OF ENDOCRINOLOGY
- Intraportal administration of DPP-IV inhibitor regulates insulin secretion and food intake mediated by the hepatic vagal afferent nerve in rats
- (2011) Kansuke Fujiwara et al. JOURNAL OF NEUROCHEMISTRY
- Novel GLP-1 mimetics developed to treat type 2 diabetes promote progenitor cell proliferation in the brain
- (2011) A. Hamilton et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Self-inducible secretion of glucagon-like peptide-1 (GLP-1) that allows MIN6 cells to maintain insulin secretion and insure cell survival
- (2011) Koji Nakashima et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Polymorphism and Ligand Dependent Changes in Human Glucagon-Like Peptide-1 Receptor (GLP-1R) Function: Allosteric Rescue of Loss of Function Mutation
- (2011) C. Koole et al. MOLECULAR PHARMACOLOGY
- B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies
- (2011) Daniel A Winer et al. NATURE MEDICINE
- The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide
- (2011) Scott E. Kanoski et al. NEUROPHARMACOLOGY
- Comparative Effects of the Long-Acting GLP-1 Receptor Ligands, Liraglutide and Exendin-4, on Food Intake and Body Weight Suppression in Rats
- (2011) Matthew R. Hayes et al. Obesity
- Glucose-dependent insulinotropic polypeptide: from pathophysiology to therapeutic opportunities in obesity-associated disorders
- (2011) E. Paschetta et al. Obesity Reviews
- Review of Liraglutide versus Sitagliptin for Patients with Uncontrolled Type 2 Diabetes: More Effective HbA1cReduction with Subcutaneous GLP-1 Receptor Agonist Versus an Oral DPP-4 Inhibitor
- (2011) Daniel A. Nadeau POSTGRADUATE MEDICINE
- Two incretin hormones GLP-1 and GIP: Comparison of their actions in insulin secretion and β cell preservation
- (2011) Daisuke Yabe et al. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
- Ghrelin and PYY in the regulation of energy balance and metabolism: lessons from mouse mutants
- (2010) Henriette Kirchner et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Pre-treatment with a DPP-4 Inhibitor is Infarct Sparing in Hearts from Obese, Pre-diabetic Rats
- (2010) Barbara Huisamen et al. CARDIOVASCULAR DRUGS AND THERAPY
- Once-Weekly GLP-1 Agonists: How Do They Differ from Exenatide and Liraglutide?
- (2010) Mikkel Christensen et al. Current Diabetes Reports
- The Glucagonostatic and Insulinotropic Effects of Glucagon-Like Peptide 1 Contribute Equally to Its Glucose-Lowering Action
- (2010) K. J. Hare et al. DIABETES
- Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?
- (2010) M. A. Nauck et al. DIABETOLOGIA
- Glucose-Dependent Insulinotropic Polypeptide Is Expressed in Pancreatic Islet α-Cells and Promotes Insulin Secretion
- (2010) Yukihiro Fujita et al. GASTROENTEROLOGY
- Effect of Glucagon-Like Peptide-1 on α- and β-Cell Function in C-Peptide-Negative Type 1 Diabetic Patients
- (2010) Urd Kielgast et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial
- (2010) Richard E Pratley et al. LANCET
- Role of the glucagon-like-peptide-1 receptor in the control of energy balance
- (2010) Matthew R. Hayes et al. PHYSIOLOGY & BEHAVIOR
- Reversal of Obesity and Insulin Resistance by a Non-Peptidic Glucagon-Like Peptide-1 Receptor Agonist in Diet-Induced Obese Mice
- (2010) Min He et al. PLoS One
- Intraislet production of GLP-1 by activation of prohormone convertase 1/3 in pancreatic α-cells in mouse models of β-cell regeneration
- (2010) German Kilimnik et al. Islets
- Selecting GLP-1 agonists in the management of type 2 diabetes: differential pharmacology and therapeutic benefits of liraglutide and exenatide
- (2010) Pinkney Therapeutics and Clinical Risk Management
- Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: Interaction between type 2 diabetes and Alzheimer's disease
- (2009) Talib Abbas et al. BEHAVIOURAL BRAIN RESEARCH
- Exenatide and liraglutide: different approaches to develop GLP-1 receptor agonists (incretin mimetics) – preclinical and clinical results
- (2009) Sten Madsbad BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of exenatide on circulating glucose, insulin, glucagon, cortisol and catecholamines in healthy volunteers during exercise
- (2009) E. Y. H. Khoo et al. DIABETOLOGIA
- Endogenous Hindbrain Glucagon-Like Peptide-1 Receptor Activation Contributes to the Control of Food Intake by Mediating Gastric Satiation Signaling
- (2009) Matthew R. Hayes et al. ENDOCRINOLOGY
- Vildagliptin Enhances Islet Responsiveness to Both Hyper- and Hypoglycemia in Patients with Type 2 Diabetes
- (2009) Bo Ahrén et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Differential expression of glucagon and glucagon-like peptide 1 receptors in mouse pancreatic alpha and beta cells in two models of alpha cell hyperplasia
- (2009) Mamdouh H. Kedees et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Dipeptydil peptidase-4 inhibitors in type 2 diabetes: A meta-analysis of randomized clinical trials
- (2009) M. Monami et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Glucose Sensing in L Cells: A Primary Cell Study
- (2008) Frank Reimann et al. Cell Metabolism
- Effects of exenatide versus sitagliptin on postprandial glucose, insulin and glucagon secretion, gastric emptying, and caloric intake: a randomized, cross-over study
- (2008) Ralph A. DeFronzo et al. CURRENT MEDICAL RESEARCH AND OPINION
- Role of Central Nervous System Glucagon-Like Peptide-1 Receptors in Enteric Glucose Sensing
- (2008) C. Knauf et al. DIABETES
- Pancreatic α-cell dysfunction in diabetes
- (2008) R. Burcelin et al. DIABETES & METABOLISM
- Caudal Brainstem Processing Is Sufficient for Behavioral, Sympathetic, and Parasympathetic Responses Driven by Peripheral and Hindbrain Glucagon-Like-Peptide-1 Receptor Stimulation
- (2008) Matthew R. Hayes et al. ENDOCRINOLOGY
- Brain Glucagon-Like Peptide 1 Signaling Controls the Onset of High-Fat Diet-Induced Insulin Resistance and Reduces Energy Expenditure
- (2008) Claude Knauf et al. ENDOCRINOLOGY
- Acute Dipeptidyl Peptidase-4 Inhibition Rapidly Enhances Insulin-Mediated Suppression of Endogenous Glucose Production in Mice
- (2008) Hélène Duez et al. ENDOCRINOLOGY
- Enhanced Protection against Cytokine- and Fatty Acid-induced Apoptosis in Pancreatic Beta Cells by Combined Treatment with Glucagon-like Peptide-1 Receptor Agonists and Insulin Analogues
- (2008) D. Tews et al. HORMONE AND METABOLIC RESEARCH
- Expression of the GLP-1 Receptor in Mouse, Rat, and Human Pancreas
- (2008) Ditte Tornehave et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started